Dorsey Wright & Associates’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Sell
16,354
-47,793
-75% -$948K 0.05% 121
2026
Q1
$1.23M Buy
64,147
+47,288
+280% +$931K 0.15% 117
2025
Q4
$319K Sell
16,859
-495
-3% -$9.17K 0.07% 119
2025
Q3
$323K Sell
17,354
-485
-3% -$9.06K 0.07% 121
2025
Q2
$329K Buy
+17,839
New +$317K 0.08% 117

Other funds holding SBRA

Dorsey Wright & Associates's SBRA Position: Q2 2026 in Review

Dorsey Wright & Associates reduced its Sabra Healthcare REIT (SBRA) stake by 75% in Q2 2026, selling an estimated $948K and leaving 16,354 shares worth $319K. The position accounts for 0.05% of the portfolio, ranked #121.

Dorsey Wright & Associates first reported a position in SBRA in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.23M in Q1 2026. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Dorsey Wright & Associates held 16,354 shares of Sabra Healthcare REIT worth $319K as of Q2 2026.
  • Dorsey Wright & Associates sold 47,793 Sabra Healthcare REIT shares in Q2 2026, an estimated $948K.
  • Sabra Healthcare REIT made up 0.05% of Dorsey Wright & Associates's portfolio in Q2 2026, its #121 holding.
  • Dorsey Wright & Associates first reported a position in Sabra Healthcare REIT in Q2 2025 and has held it in 5 quarters since.
  • Dorsey Wright & Associates's Sabra Healthcare REIT position peaked at $1.23M in Q1 2026.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.